Literature DB >> 16807955

Optimising non-viral gene delivery in a tumour spheroid model.

H R Mellor1, L A Davies, H Caspar, C R Pringle, S C Hyde, D R Gill, R Callaghan.   

Abstract

BACKGROUND: Our current understanding of how the unique tumour microenvironment influences the efficacy of gene delivery is limited. The current investigation systematically examines the efficiency of several non-viral gene transfer agents to transfect multicellular tumour spheroids (MCTS), an in vitro model that displays a faithful three-dimensional (3D) representation of solid tumour tissue.
METHODS: Using a luciferase reporter assay, gene transfer to MCTS was optimised for 22 kDa linear and 25 kDa branched polyethyleneimine (PEI), the cationic lipids Lipofectamine(trade mark) and DCChol : DOPE, and the physical approach of tissue electroporation. Confocal microscopy was used to take optical tissue slices to identify the tissue localisation of green fluorescent protein (GFP) reporter gene expression and the distribution of fluorescently labelled complexes. A MCTS model of quiescent tumour regions was used to establish the influence of cellular proliferation status on gene transfer efficiency.
RESULTS: Of the polyplexes tested, 22 kDa linear PEI provided optimal gene delivery, with gene expression peaking at 46 h. Despite being the optimal vector tested, PEI-mediated transfection was limited to cells at the MCTS periphery. Using fluorescent PEI, it was found that complexes could only penetrate the outer 3-5 proliferating cell layers of the MCTS, sparing the deeper quiescent cells. Gene delivery in an MCTS model comprised entirely of quiescent cells demonstrated that in addition to being inaccessible to the vector, quiescent tumour regions are inherently less susceptible to PEI-mediated transfection than proliferating regions. This 'resistance' to transfection observed in quiescent cells was overcome through the use of electroporation. Despite the improved efficacy of electroporation in quiescent tissue, the gene expression was still confined to the outer regions of MCTS. The results suggest that limited access to central regions of an MCTS remain a significant barrier to gene delivery.
CONCLUSIONS: This data provides new insights into tumour-specific factors affecting non-viral gene transfer and highlights the difficulties in delivering genes to avascular tumour regions. The MCTS model is a useful system for the initial screening of future gene therapy strategies for solid tumours. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807955     DOI: 10.1002/jgm.947

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  17 in total

1.  Binding and transport of PAMAM-RGD in a tumor spheroid model: the effect of RGD targeting ligand density.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Biotechnol Bioeng       Date:  2011-07-19       Impact factor: 4.530

Review 2.  Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery.

Authors:  Christopher L Grigsby; Kam W Leong
Journal:  J R Soc Interface       Date:  2009-09-04       Impact factor: 4.118

3.  The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic cultures.

Authors:  Nupura S Bhise; Ryan S Gray; Joel C Sunshine; Soe Htet; Andrew J Ewald; Jordan J Green
Journal:  Biomaterials       Date:  2010-07-31       Impact factor: 12.479

Review 4.  Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Crit Rev Biomed Eng       Date:  2012

5.  3D spheroids' sensitivity to electric field pulses depends on their size.

Authors:  Laure Gibot; Marie-Pierre Rols
Journal:  J Membr Biol       Date:  2013-03-22       Impact factor: 1.843

6.  Efficient In Vitro Electropermeabilization of Reconstructed Human Dermal Tissue.

Authors:  Moinecha Madi; Marie-Pierre Rols; Laure Gibot
Journal:  J Membr Biol       Date:  2015-03-19       Impact factor: 1.843

Review 7.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

8.  Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells.

Authors:  Chiara De Santi; Elena Fernández Fernández; Rachel Gaul; Sebastian Vencken; Arlene Glasgow; Irene K Oglesby; Killian Hurley; Finn Hawkins; Nilay Mitash; Fangping Mu; Rana Raoof; David C Henshall; Meritxell B Cutrona; Jeremy C Simpson; Brian J Harvey; Barry Linnane; Paul McNally; Sally Ann Cryan; Ronan MacLoughlin; Agnieszka Swiatecka-Urban; Catherine M Greene
Journal:  Mol Ther       Date:  2020-02-06       Impact factor: 11.454

9.  PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Bioconjug Chem       Date:  2009-09-23       Impact factor: 4.774

Review 10.  3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers.

Authors:  Thomas Tyrel Goodman; Chee Ping Ng; Suzie Hwang Pun
Journal:  Bioconjug Chem       Date:  2008-09-13       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.